Frontiers in bioengineering and biotechnology · 2026
Anti-fibrotic effect of Spirulina maxima-derived extracellular vesicles: possible role of PARK7 and HSP70 chaperones.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Szebeni Beáta, Bernáth Mária, Bokrossy Péter, Pap Domonkos, Molnár Zoltán, Mészáros Tamás, Lenzinger Dorina, Visnovitz Tamás, Pálmai Marcell, Mihály Judith, Varga Zoltán, Fekete Nóra, Pállinger Éva, Veres-Székely Apor, Szász Csenge, Buzás Edit, Szabó Attila J, Vannay Ádám
Аннотация
INTRODUCTION: Spirulina maxima (Sm), a blue-green microalgae, is well known for its rich nutritional composition, antioxidant, and anti-inflammatory properties. In this study, we found that small extracellular vesicles (sEVs) isolated from Sm exhibit antifibrotic activity.
METHODS: Sm derived sEVs (Sm_sEV) were purified from the Sm culture medium using tangential flow filtration (TFF), followed by size-exclusion chromatography (SEC). Characterization of the sEVs was performed using nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), immunogold TEM, surface-enhanced IR spectroscopy (SEIRS), and flow cytometry (FC). Internalization of DiI-labeled sEVs by human primary peritoneal mesothelial cells (P-MCs) and peritoneal fibroblasts (p-FBs) was examined using fluorescence microscopy. The effect of sEVs on mesenchymal transition of P-MCs and activation of P-FBs was investigated by immunofluorescent staining, MTT cell-proliferation, and Sirius Red collagen accumulation assays, respectively. The antifibrotic relevance of Sm_sEV was further investigated in a chlorhexidine digluconate (CG)-induced mouse model of peritoneal fibrosis.
RESULTS: The isolated Sm_sEV exhibited a spherical morphology, with a size range of 150.0 ± 67.6 nm, and the protein-to-lipid ratio (P/L_spectr) was 2.27 ± 0.07. The sEVs cargo contained Parkinson's disease protein 7 (PARK7), and heat shock protein 70 (HSP70). DiI-labeled sEVs were successfully internalized by both P-MCs and P-FBs and inhibited TGF-β-induced mesenchymal transition in P-MCs and the collagen production and PDGF-B-induced proliferation in P-FBs. In vivo, intraperitoneal administration of Sm_sEVs reduced CG-induced submesothelial thickening, fibronectin, and collagen type I alpha 1 immunopositivity, and increased cytokeratin 18, immunopositivity in the mesothelial layer.
DISCUSSION: These findings highlight the antifibrotic effect of Sm_sEV and support their further investigation in the context of fibrosis.
METHODS: Sm derived sEVs (Sm_sEV) were purified from the Sm culture medium using tangential flow filtration (TFF), followed by size-exclusion chromatography (SEC). Characterization of the sEVs was performed using nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), immunogold TEM, surface-enhanced IR spectroscopy (SEIRS), and flow cytometry (FC). Internalization of DiI-labeled sEVs by human primary peritoneal mesothelial cells (P-MCs) and peritoneal fibroblasts (p-FBs) was examined using fluorescence microscopy. The effect of sEVs on mesenchymal transition of P-MCs and activation of P-FBs was investigated by immunofluorescent staining, MTT cell-proliferation, and Sirius Red collagen accumulation assays, respectively. The antifibrotic relevance of Sm_sEV was further investigated in a chlorhexidine digluconate (CG)-induced mouse model of peritoneal fibrosis.
RESULTS: The isolated Sm_sEV exhibited a spherical morphology, with a size range of 150.0 ± 67.6 nm, and the protein-to-lipid ratio (P/L_spectr) was 2.27 ± 0.07. The sEVs cargo contained Parkinson's disease protein 7 (PARK7), and heat shock protein 70 (HSP70). DiI-labeled sEVs were successfully internalized by both P-MCs and P-FBs and inhibited TGF-β-induced mesenchymal transition in P-MCs and the collagen production and PDGF-B-induced proliferation in P-FBs. In vivo, intraperitoneal administration of Sm_sEVs reduced CG-induced submesothelial thickening, fibronectin, and collagen type I alpha 1 immunopositivity, and increased cytokeratin 18, immunopositivity in the mesothelial layer.
DISCUSSION: These findings highlight the antifibrotic effect of Sm_sEV and support their further investigation in the context of fibrosis.